Enantioseparation of Proton Pump Inhibitors by HPLC on Polysaccharide-Type Stationary Phases: Enantiomer Elution Order Reversal, Thermodynamic Characterization, and Hysteretic Effect. [PDF]
Dobó M +6 more
europepmc +1 more source
Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database. [PDF]
Wang Z, Jin J, Wang G, Zhou G, Jiang H.
europepmc +1 more source
Post-translational modifications of triosephosphate isomerase reveal metabolic vulnerabilities in T-ALL: effect of combining dichloroacetic acid and the PPI rabeprazole. [PDF]
Martínez-Pérez Y +12 more
europepmc +1 more source
Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Priyadharshini A +4 more
europepmc +1 more source
Severe Agranulocytosis and Thyroid Storm Triggered by Reinitiating Low-Dose Thiamazole: A Cautionary Case. [PDF]
Minamoto Y +5 more
europepmc +1 more source
Rabeprazole- and vonoprazan-based dual therapies for H pylori eradication: effective with low side effects, rabeprazole being more cost-effective. [PDF]
Sun X, Li D, Cui L, Du S, Wang X, Wu N.
europepmc +1 more source
Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations. [PDF]
Mu Y, Zhou Y, Zhang X, Shao Y.
europepmc +1 more source
Eradication of Helicobacter pylori that contributes to hepatogenic ulcer is beneficial to the healing of hepatogenic ulcer. [PDF]
Qiao G +8 more
europepmc +1 more source
Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBase. [PDF]
Chretien B +6 more
europepmc +1 more source

